Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9609518 | 0.80 | MAPT (0.36) | DAOMAPTALDH1A1KMT2APOLB | |
| SCHEMBL3936524 | 0.78 | MAPT (0.38) | MAPTALDH1A1KMT2APOLBMEN1 | |
| SCHEMBL4869101 | 0.74 | MAPT (0.35) | DAOMAPTALDH1A1KMT2APOLB | |
| SCHEMBL3505646 | 0.73 | GPR84 (0.40) | KMT2A | |
| SCHEMBL3938297 | 0.73 | — | — | |
| SCHEMBL6282240 | 0.72 | GPR84 (0.42) | — | |
| SCHEMBL5511874 | 0.71 | MEN1 (0.31) | KMT2AMEN1 | |
| SCHEMBL4865720 | 0.71 | ALOX5 (0.34) | DAOSMN1; SMN2MAPTALDH1A1KMT2A | |
| SCHEMBL9688152 | 0.71 | ALDH1A1 (0.35) | MAPTALDH1A1POLB | |
| SCHEMBL11690801 | 0.70 | MAPT (0.30) | MAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11634659-B2 | Fragrances with rose scent | SYMRISE AG (DE) | 2023-04-25 | — | — | US | disclosed |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | SYMRISE AG (DE) | 2021-10-21 | — | — | US | disclosed |
| WO-2020020434-A1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2020-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634659-B2 | Fragrances with rose scent | NR1H2, DUOX2, AOX1 | DAO 625/4885SMN1; SMN2 4131/4885MAPT 1597/4885 |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | NR1H2, DUOX2, AOX1 | DAO 740/4885SMN1; SMN2 3983/4885MAPT 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.